-
Something wrong with this record ?
The Gastroepiploic Vascularized Lymph Node Transfer in the Treatment of Male Genital Lymphedema: A Report of Three Cases
M. Morelli Coppola, W. Gawel, R. Elia, E. Uldry, M. Nicod Lalonde, M. Maruccia, PG. di Summa
Language English Country United States
Document type Case Reports, Journal Article
PubMed
40439457
DOI
10.1002/micr.70072
Knihovny.cz E-resources
- MeSH
- Gastroepiploic Artery * transplantation MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Lymph Nodes * transplantation blood supply MeSH
- Lymphedema * surgery etiology MeSH
- Genital Diseases, Male * surgery MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
Male genital lymphedema (MGL) is a debilitating condition that may require surgical intervention. Lymphaticovenous anastomosis (LVA) can be ineffective in primary and advanced cases because of lymphatic disruption, whereas vascularized lymph node transfer (VLNT) can overcome this limitation by promoting neolymphangiogenesis but traditionally carries some risk of donor site complications. Gastroepiploic vascularized lymph node transfer (GEVLNT) has recently emerged as an effective treatment option for upper and lower limb lymphedema, with negligible complications. However, its role in genital lymphedema remains unexplored. This is the first short series reporting the use of GEVLNT in MGL. Three male patients (44, 61, and 52 years old) with GL underwent GEVLNT. The first patient had idiopathic disease, which relapsed after previous treatment with LVA; the other two had secondary lymphedema due to cancer treatment and hydrocele surgery, respectively. In all patients, the right gastroepiploic lymphosome was harvested laparoscopically, with flap sizes of 14 × 5 cm, 15 × 4 cm, and 12 × 4 cm, respectively. The recipient vessels were the deep inferior epigastric artery and vein in the first case, and the superficial external pudendal vessels in the other two. Post-operative courses were uneventful for all patients, with no complications reported. Follow-up periods were 36, 23, and 12 months, respectively. In all cases, GEVLNT resulted in significant clinical improvements and reductions in genital lymphedema severity (GLS) scores (7-1, 9-4, and 8-4). Our preliminary experience suggests that GEVLNT could be a viable and effective option for treating male genital lymphedema with minimal donor site morbidity and stable results over time. However, further research with larger patient cohorts, comparative studies, and long-term follow-up is needed to fully establish its efficacy.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015173
- 003
- CZ-PrNML
- 005
- 20250731090811.0
- 007
- ta
- 008
- 250708s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/micr.70072 $2 doi
- 035 __
- $a (PubMed)40439457
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Morelli Coppola, Marco $u Operative Research Unit of Plastic, Reconstructive and Aesthetic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy $u Department of Plastic and Hand Surgery, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland $1 https://orcid.org/0000000289106586
- 245 14
- $a The Gastroepiploic Vascularized Lymph Node Transfer in the Treatment of Male Genital Lymphedema: A Report of Three Cases / $c M. Morelli Coppola, W. Gawel, R. Elia, E. Uldry, M. Nicod Lalonde, M. Maruccia, PG. di Summa
- 520 9_
- $a Male genital lymphedema (MGL) is a debilitating condition that may require surgical intervention. Lymphaticovenous anastomosis (LVA) can be ineffective in primary and advanced cases because of lymphatic disruption, whereas vascularized lymph node transfer (VLNT) can overcome this limitation by promoting neolymphangiogenesis but traditionally carries some risk of donor site complications. Gastroepiploic vascularized lymph node transfer (GEVLNT) has recently emerged as an effective treatment option for upper and lower limb lymphedema, with negligible complications. However, its role in genital lymphedema remains unexplored. This is the first short series reporting the use of GEVLNT in MGL. Three male patients (44, 61, and 52 years old) with GL underwent GEVLNT. The first patient had idiopathic disease, which relapsed after previous treatment with LVA; the other two had secondary lymphedema due to cancer treatment and hydrocele surgery, respectively. In all patients, the right gastroepiploic lymphosome was harvested laparoscopically, with flap sizes of 14 × 5 cm, 15 × 4 cm, and 12 × 4 cm, respectively. The recipient vessels were the deep inferior epigastric artery and vein in the first case, and the superficial external pudendal vessels in the other two. Post-operative courses were uneventful for all patients, with no complications reported. Follow-up periods were 36, 23, and 12 months, respectively. In all cases, GEVLNT resulted in significant clinical improvements and reductions in genital lymphedema severity (GLS) scores (7-1, 9-4, and 8-4). Our preliminary experience suggests that GEVLNT could be a viable and effective option for treating male genital lymphedema with minimal donor site morbidity and stable results over time. However, further research with larger patient cohorts, comparative studies, and long-term follow-up is needed to fully establish its efficacy.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a lymfedém $x chirurgie $x etiologie $7 D008209
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a lymfatické uzliny $x transplantace $x krevní zásobení $7 D008198
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a arteria gastroepiploica $x transplantace $7 D024405
- 650 12
- $a nemoci mužských pohlavních orgánů $x chirurgie $7 D005832
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gawel, Wladyslaw $u Centre for Plastic and Hand Surgery, University Hospital in Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Elia, Rossella $u Department of Plastic and Reconstructive Surgery, Policlinico di Bari, University of Bari Aldo Moro, Bari, Italy
- 700 1_
- $a Uldry, Emilie $u Department of Visceral Surgery, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Nicod Lalonde, Marie $u Department of Nuclear Medicine and Molecular Imaging, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Maruccia, Michele $u Department of Plastic and Reconstructive Surgery, Policlinico di Bari, University of Bari Aldo Moro, Bari, Italy $1 https://orcid.org/0000000221222732
- 700 1_
- $a di Summa, Pietro Giovanni $u Department of Plastic and Hand Surgery, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland $1 https://orcid.org/0000000214314479
- 773 0_
- $w MED00003349 $t Microsurgery $x 1098-2752 $g Roč. 45, č. 5 (2025), s. e70072
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40439457 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731090805 $b ABA008
- 999 __
- $a ok $b bmc $g 2366182 $s 1252298
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 45 $c 5 $d e70072 $e - $i 1098-2752 $m Microsurgery $n Microsurgery $x MED00003349
- LZP __
- $a Pubmed-20250708